Case Study: Avanir Pharmaceuticals achieves increased MSL proficiency and 92% engagement with Qstream

Avanir Pharmaceuticals’ MSLs Leverage Qstream to Drive Value-Added Physician Conversations

Avanir Pharmaceuticals, a biopharmaceutical company focused on treatments for central nervous system disorders, relied on Medical Science Liaisons (MSLs) to educate clinicians and support product adoption. The challenge was keeping MSLs fluent across a broad, evolving set of scientific, clinical and competitive topics between formal trainings—an approach that left teams reading articles or slides without consistent practice or measurable reinforcement.

Avanir deployed Qstream’s mobile, scenario-based platform to push short challenges to MSLs, use leaderboards to drive engagement, and apply analytics to identify proficiency gaps and trigger targeted coaching. In five weeks proficiency on key topics rose from 64% to 82% with 92% engagement, delivering stronger fluency, higher training ROI and better-prepared MSLs for value-added physician conversations.

Avanir Pharmaceuticals

John Drum

Senior Director, Medical Affairs